Western blot assays showed that enzalutamide upregulated the levels TGF-β1 in all three tested prostate cancer cell lines (Figures 4a–c) and metformin is able to counteract enzalutamide upregulated TGF-β1. This evidence concerns the gene TGFB1 and prostate cancer.